CNBC’s Meg Tirrell reports on Moderna’s phase 1 vaccine results. Jefferies Managing Director Michael Yee discusses with CNBC’s Melissa Lee and the Fast Money traders, Guy Adami, Dan Nathan, Carter Worth and Bonawyn Eisen. For access to live and exclusive…
Dr. Scott Gottlieb, member of the boards of Pfizer, Tempus and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss the latest news on the coronavirus pandemic. For more coronavirus live updates: For access to live and…
Dr. Scott Gottlieb, member of the boards of Pfizer, Tempus and biotech company Illumina and former FDA commissioner, tells CNBC’s “Squawk Box” he believes the Covid-19 pandemic will end within six months either because there will be widespread access to…
CNBC’s Jim Cramer said Wednesday that he was surprised Pfizer released promising early data on its coronavirus vaccine, but suggested it was a sign of confidence from the U.S. pharmaceutical giant. For access to live and exclusive video from CNBC subscribe…
Dr. Ian Lipkin, Director of the Center for Infection and Immunity at Columbia, joins “Closing Bell” to discuss the coronavirus pandemic.
Scientists still don’t know whether coronavirus antibodies give a person immunity or reduce the risk of reinfection, even as some nations consider issuing passports or certificates that indicate whether someone has had the virus, World Health Organization officials said Monday.…
